查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1641762

全球熱療設備市場（按產品、應用和最終用戶分類）- 機會分析和產業預測，2024 年至 2033 年

Hyperthermia Devices Market By Product , By Application By End User : Global Opportunity Analysis and Industry Forecast, 2024-2033
出版日期: | 出版商: Allied Market Research | 英文 290 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

高溫治療設備市場規模預計在 2023 年將達到 1.682 億美元，到 2033 年將達到 2.901 億美元，2024 年至 2033 年的複合年成長率為 5.6%。

高溫治療設備市場-IMG1

高溫機是醫療設備，通常作為癌症的輔助治療。透過對身體特定部位進行控制加熱，可以改善血液流動並使癌細胞更容易接受治療，從而增強化療和放射線治療等治療效果。

全球熱療市場的成長是由全球癌症患者數量的增加所推動的，這推動了對創新治療方法，包括熱療設備，以提高化療和放射線治療等傳統癌症治療的有效性。根據世界衛生組織 (WHO) 2022 年發布的一項研究，癌症是全球主要死亡原因，2020 年導致約 1000 萬人死亡。因此，隨著越來越多的患者尋求微創的癌症治療方法，熱療設備因其能夠針對局部組織同時與傳統方法相比最大限度地減少副作用而越來越受歡迎。此外，人們越來越認知到熱療的益處，包括其在改善治療結果和減少副作用方面的作用，導致其在臨床實踐中的接受度越來越高。此外，人們越來越意識到熱療的益處，包括其在改善治療結果和減少副作用方面的作用，這使得其在臨床環境中得到更廣泛的接受，從而推動了市場的成長。此外，老年人口的快速增加是全球市場的主要動力。這是因為老齡化與免疫系統效率降低有關，包括控制異常和癌細胞的能力下降。這對包括熱療設備在內的先進治療方案產生了巨大的需求。世界衛生組織（WHO）2024年發布的一項研究顯示，老年人口數量將從2020年的10億增加到2030年的14億。此外，到2050年，80歲及以上人口數量預計將達到4.26億人。全球專科腫瘤診所和醫院數量的不斷成長，進一步推動了熱療等先進癌症治療方法的採用，以改善患者的治療效果。儘管熱療有許多好處，但由於醫療保健提供者對其功效及其與癌症治療方案的結合程度的認知和培訓有限，熱療仍未得到充分利用。高溫治療的成本（包括設備和相關程序）對於許多患者和醫療保健系統來說是難以承受的，特別是在中低收入地區，這進一步抑制了市場的成長。相反，改進的熱傳輸系統、即時溫度監測和非侵入式設備等技術創新正在使熱療治療更加安全、準確和有效。預計這些發展將為預測期內全球市場的擴張提供有利可圖的機會。

全球熱療設備市場分析分為產品、應用、最終用戶和地區。根據產品，市場分為微波熱療設備和超音波熱療設備。依用途分為乳癌、攝護腺癌、子宮頸癌等。根據最終用戶，市場分為醫院、癌症治療中心和其他。根據地區，分析範圍涵蓋北美、歐洲、亞太地區、拉丁美洲以及中東和非洲。

主要發現

根據產品，超音波熱療設備領域預計將在 2024 年至 2033 年期間佔據市場主導地位。

根據應用，預計前列腺癌部分將在整個預測期內呈現最高成長。

根據最終用戶，醫院部門預計在預測期內將大幅成長。

根據地區，預計北美將在 2023 年佔據最大的市場佔有率（以收益為準） ，並且很可能在預測期內繼續佔據市場主導地位。

全球高溫設備市場的主要企業包括 Pyrexar Medical、Oncotherm、Celsius42、Andromedic、Pearson、南京 Greathope、上海華遠、MagForce AG、Nanopores 和 Sensius。這些主要企業正在採取業務擴張、新產品推出和聯盟等各種關鍵發展策略，以在競爭激烈的市場中站穩腳跟。

此報告可進行客製化（可能需要支付額外費用和製定時間表）

  • 國家、地區和全球層面的患者/流行病學資料
  • 監管指南
  • 根據客戶興趣提供額外的公司簡介
  • 按國家或地區進行的額外分析 - 市場規模和預測
  • 擴展公司簡介列表
  • 歷史市場資料
  • SWOT 分析

目錄

第 1 章 簡介

第 2 章執行摘要

第3章 市場狀況

  • 市場定義和範圍
  • 主要發現
    • 重大投資機會
    • 關鍵成功策略
  • 波特五力分析
  • 市場動態
    • 驅動程式
    • 限制因素
    • 機會

第4章 熱療設備市場（依產品）

  • 市場概況
  • 微波熱療裝置
  • 超音波熱療儀

第5章 熱療設備市場依應用

  • 市場概況
  • 乳癌
  • 攝護腺癌
  • 子宮頸癌
  • 其他

第6章 熱療設備市場（依最終用戶）

  • 市場概況
  • 醫院
  • 癌症治療中心
  • 其他

第7章 熱療設備市場（按地區）

  • 市場概況
  • 北美洲
    • 主要市場趨勢和機遇
    • 美國高溫設備市場
    • 加拿大高溫設備市場
    • 墨西哥的高溫治療設備市場
  • 歐洲
    • 主要市場趨勢和機遇
    • 法國熱療設備市場
    • 德國熱療設備市場
    • 義大利熱療設備市場
    • 西班牙高溫設備市場
    • 英國熱療設備市場
    • 其他歐洲國家熱療設備市場
  • 亞太地區
    • 主要市場趨勢和機遇
    • 中國熱療設備市場
    • 日本熱療設備市場
    • 印度熱療設備市場
    • 韓國熱療設備市場
    • 澳洲熱療設備市場
    • 其他亞太地區熱療設備市場
  • 拉丁美洲、中東和非洲
    • 主要市場趨勢和機遇
    • 巴西熱療設備市場
    • 南非熱療設備市場
    • 沙烏地阿拉伯的高溫治療設備市場
    • 其他拉丁美洲、中東和非洲熱療設備市場

第8章 競爭格局

  • 介紹
  • 關鍵成功策略
  • 前 10 家公司的產品映射
  • 競爭儀錶板
  • 競爭熱圖
  • 2023年主要企業的定位

第9章 公司簡介

  • Pyrexar Medical
  • Oncotherm
  • Celsius42
  • Andromedic
  • Pearson
  • Nanjing Greathope
  • Shanghai Huayuan
  • MagForce AG
  • Nanopores
  • Sensius
簡介目錄
Product Code: A324444

The hyperthermia devices market was valued at $168.2 million in 2023, and is projected to reach $290.1 million by 2033, growing at a CAGR of 5.6% from 2024 to 2033.

Hyperthermia Devices Market - IMG1

Hyperthermia devices are medical instruments used to raise the temperature of body tissues for therapeutic purposes, often as an adjunct treatment for cancer. By applying controlled heat to specific areas of the body, these devices enhance the efficacy of treatments like chemotherapy and radiation therapy by improving blood flow and increasing the sensitivity of cancer cells to treatment.

The growth of the global hyperthermia devices market is driven by global increase in cancer cases has driven demand for innovative treatment modalities, including hyperthermia devices, which improve the efficacy of traditional cancer therapies like chemotherapy and radiation. According to a 2022 study published by the World Health Organization, cancer is a leading cause of death worldwide, which accounted for nearly 10 million deaths in 2020. Thus, with patients increasingly seeking less invasive cancer treatments, hyperthermia devices have gained popularity due to their ability to target localized tissues with minimal side effects compared to conventional approaches. In addition, increase in awareness about the benefits of hyperthermia therapy, including its role in enhancing treatment outcomes and reducing side effects, has led to higher acceptance in clinical practice. Moreover, rise in awareness about the benefits of hyperthermia therapy, including its role in enhancing treatment outcomes and reducing side effects, has led to higher acceptance in clinical practice, thus fostering the market growth. Furthermore, surge in geriatric population acts as the key driving force of the global market. This is attributed to the fact that aging is associated with a decline in immune system efficiency, including reduced surveillance for abnormal or cancerous cells. This has created a significant demand for advanced therapeutic options, including hyperthermia devices. A 2024 study published by the World Health Organization revealed that the number of aged individuals will increase from 1 billion in 2020 to 1.4 billion by 2030. Moreover, the number of individuals aging 80 years and older is estimated to reach 426 million by 2050. The growth of specialized oncology clinics and hospitals worldwide has further facilitated the adoption of advanced cancer treatment modalities, such as hyperthermia therapy, to improve patient outcomes. Despite its benefits, hyperthermia therapy remains underutilized due to limited awareness and training among healthcare providers about its effectiveness and integration into cancer treatment protocols. The cost of hyperthermia treatment, including the devices and associated procedures, can be prohibitive for many patients and healthcare systems, particularly in low- and middle-income regions, further restraining the market growth. On the contrary, Technological innovations, such as improved thermal delivery systems, real-time temperature monitoring, and non-invasive devices, have enhanced the safety, precision, and effectiveness of hyperthermia treatments. Such developments are expected to offer remunerative opportunities for the expansion of the global market during the forecast period.

The global hyperthermia devices market analysis is segmented into product, application, end user, and region. On the basis of product, the market is categorized into microwave hyperthermia devices and ultrasound hyperthermia devices. Depending on application, it is segregated into breast cancer, prostate cancer, cervical cancer, and others. By end user, it is fragmented into hospitals, cancer treatment centers, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of product, the ultrasound hyperthermia devices segment is expected to dominate the market from 2024 to 2033.

Depending on application, the prostate cancer segment is anticipated to exhibit the highest growth throughout the forecast period.

By end user, the hospitals segment is projected to grow at a notable pace during the forecast period.

Region wise, North America held the largest market share, in terms of revenue, in 2023, and is likely to dominate the market during the forecast period.

Competition Analysis

The major players operating in the global hyperthermia devices Market include Pyrexar Medical, Oncotherm, Celsius42, Andromedic, Pearson, Nanjing Greathope, Shanghai Huayuan, MagForce AG, Nanopores, and Sensius. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the competitive market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Patient/epidemiology data at country, region, global level
  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • SWOT Analysis

Key Market Segments

By Product

  • Microwave Hyperthermia Devices
  • Ultrasound Hyperthermia Devices

By Application

  • Breast Cancer
  • Prostate Cancer
  • Cervical Cancer
  • Others

By End User

  • Hospitals
  • Cancer treatment centers
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • UK
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA

Key Market Players:

    • Pyrexar Medical
    • Oncotherm
    • Celsius42
    • Andromedic
    • Pearson
    • Nanjing Greathope
    • Shanghai Huayuan
    • MagForce AG
    • Nanopores
    • Sensius

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: HYPERTHERMIA DEVICES MARKET, BY PRODUCT

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Product
  • 4.2. Microwave Hyperthermia Devices
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Ultrasound Hyperthermia Devices
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country

CHAPTER 5: HYPERTHERMIA DEVICES MARKET, BY APPLICATION

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Application
  • 5.2. Breast Cancer
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Prostate Cancer
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country
  • 5.4. Cervical Cancer
    • 5.4.1. Key Market Trends, Growth Factors and Opportunities
    • 5.4.2. Market Size and Forecast, By Region
    • 5.4.3. Market Share Analysis, By Country
  • 5.5. Others
    • 5.5.1. Key Market Trends, Growth Factors and Opportunities
    • 5.5.2. Market Size and Forecast, By Region
    • 5.5.3. Market Share Analysis, By Country

CHAPTER 6: HYPERTHERMIA DEVICES MARKET, BY END USER

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By End User
  • 6.2. Hospitals
    • 6.2.1. Key Market Trends, Growth Factors and Opportunities
    • 6.2.2. Market Size and Forecast, By Region
    • 6.2.3. Market Share Analysis, By Country
  • 6.3. Cancer Treatment Centers
    • 6.3.1. Key Market Trends, Growth Factors and Opportunities
    • 6.3.2. Market Size and Forecast, By Region
    • 6.3.3. Market Share Analysis, By Country
  • 6.4. Others
    • 6.4.1. Key Market Trends, Growth Factors and Opportunities
    • 6.4.2. Market Size and Forecast, By Region
    • 6.4.3. Market Share Analysis, By Country

CHAPTER 7: HYPERTHERMIA DEVICES MARKET, BY REGION

  • 7.1. Market Overview
    • 7.1.1 Market Size and Forecast, By Region
  • 7.2. North America
    • 7.2.1. Key Market Trends and Opportunities
    • 7.2.2. Market Size and Forecast, By Product
    • 7.2.3. Market Size and Forecast, By Application
    • 7.2.4. Market Size and Forecast, By End User
    • 7.2.5. Market Size and Forecast, By Country
    • 7.2.6. U.S. Hyperthermia Devices Market
      • 7.2.6.1. Market Size and Forecast, By Product
      • 7.2.6.2. Market Size and Forecast, By Application
      • 7.2.6.3. Market Size and Forecast, By End User
    • 7.2.7. Canada Hyperthermia Devices Market
      • 7.2.7.1. Market Size and Forecast, By Product
      • 7.2.7.2. Market Size and Forecast, By Application
      • 7.2.7.3. Market Size and Forecast, By End User
    • 7.2.8. Mexico Hyperthermia Devices Market
      • 7.2.8.1. Market Size and Forecast, By Product
      • 7.2.8.2. Market Size and Forecast, By Application
      • 7.2.8.3. Market Size and Forecast, By End User
  • 7.3. Europe
    • 7.3.1. Key Market Trends and Opportunities
    • 7.3.2. Market Size and Forecast, By Product
    • 7.3.3. Market Size and Forecast, By Application
    • 7.3.4. Market Size and Forecast, By End User
    • 7.3.5. Market Size and Forecast, By Country
    • 7.3.6. France Hyperthermia Devices Market
      • 7.3.6.1. Market Size and Forecast, By Product
      • 7.3.6.2. Market Size and Forecast, By Application
      • 7.3.6.3. Market Size and Forecast, By End User
    • 7.3.7. Germany Hyperthermia Devices Market
      • 7.3.7.1. Market Size and Forecast, By Product
      • 7.3.7.2. Market Size and Forecast, By Application
      • 7.3.7.3. Market Size and Forecast, By End User
    • 7.3.8. Italy Hyperthermia Devices Market
      • 7.3.8.1. Market Size and Forecast, By Product
      • 7.3.8.2. Market Size and Forecast, By Application
      • 7.3.8.3. Market Size and Forecast, By End User
    • 7.3.9. Spain Hyperthermia Devices Market
      • 7.3.9.1. Market Size and Forecast, By Product
      • 7.3.9.2. Market Size and Forecast, By Application
      • 7.3.9.3. Market Size and Forecast, By End User
    • 7.3.10. UK Hyperthermia Devices Market
      • 7.3.10.1. Market Size and Forecast, By Product
      • 7.3.10.2. Market Size and Forecast, By Application
      • 7.3.10.3. Market Size and Forecast, By End User
    • 7.3.11. Rest Of Europe Hyperthermia Devices Market
      • 7.3.11.1. Market Size and Forecast, By Product
      • 7.3.11.2. Market Size and Forecast, By Application
      • 7.3.11.3. Market Size and Forecast, By End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key Market Trends and Opportunities
    • 7.4.2. Market Size and Forecast, By Product
    • 7.4.3. Market Size and Forecast, By Application
    • 7.4.4. Market Size and Forecast, By End User
    • 7.4.5. Market Size and Forecast, By Country
    • 7.4.6. China Hyperthermia Devices Market
      • 7.4.6.1. Market Size and Forecast, By Product
      • 7.4.6.2. Market Size and Forecast, By Application
      • 7.4.6.3. Market Size and Forecast, By End User
    • 7.4.7. Japan Hyperthermia Devices Market
      • 7.4.7.1. Market Size and Forecast, By Product
      • 7.4.7.2. Market Size and Forecast, By Application
      • 7.4.7.3. Market Size and Forecast, By End User
    • 7.4.8. India Hyperthermia Devices Market
      • 7.4.8.1. Market Size and Forecast, By Product
      • 7.4.8.2. Market Size and Forecast, By Application
      • 7.4.8.3. Market Size and Forecast, By End User
    • 7.4.9. South Korea Hyperthermia Devices Market
      • 7.4.9.1. Market Size and Forecast, By Product
      • 7.4.9.2. Market Size and Forecast, By Application
      • 7.4.9.3. Market Size and Forecast, By End User
    • 7.4.10. Australia Hyperthermia Devices Market
      • 7.4.10.1. Market Size and Forecast, By Product
      • 7.4.10.2. Market Size and Forecast, By Application
      • 7.4.10.3. Market Size and Forecast, By End User
    • 7.4.11. Rest of Asia-Pacific Hyperthermia Devices Market
      • 7.4.11.1. Market Size and Forecast, By Product
      • 7.4.11.2. Market Size and Forecast, By Application
      • 7.4.11.3. Market Size and Forecast, By End User
  • 7.5. LAMEA
    • 7.5.1. Key Market Trends and Opportunities
    • 7.5.2. Market Size and Forecast, By Product
    • 7.5.3. Market Size and Forecast, By Application
    • 7.5.4. Market Size and Forecast, By End User
    • 7.5.5. Market Size and Forecast, By Country
    • 7.5.6. Brazil Hyperthermia Devices Market
      • 7.5.6.1. Market Size and Forecast, By Product
      • 7.5.6.2. Market Size and Forecast, By Application
      • 7.5.6.3. Market Size and Forecast, By End User
    • 7.5.7. South Africa Hyperthermia Devices Market
      • 7.5.7.1. Market Size and Forecast, By Product
      • 7.5.7.2. Market Size and Forecast, By Application
      • 7.5.7.3. Market Size and Forecast, By End User
    • 7.5.8. Saudi Arabia Hyperthermia Devices Market
      • 7.5.8.1. Market Size and Forecast, By Product
      • 7.5.8.2. Market Size and Forecast, By Application
      • 7.5.8.3. Market Size and Forecast, By End User
    • 7.5.9. Rest of LAMEA Hyperthermia Devices Market
      • 7.5.9.1. Market Size and Forecast, By Product
      • 7.5.9.2. Market Size and Forecast, By Application
      • 7.5.9.3. Market Size and Forecast, By End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top Winning Strategies
  • 8.3. Product Mapping Of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

  • 9.1. Pyrexar Medical
    • 9.1.1. Company Overview
    • 9.1.2. Key Executives
    • 9.1.3. Company Snapshot
    • 9.1.4. Operating Business Segments
    • 9.1.5. Product Portfolio
    • 9.1.6. Business Performance
    • 9.1.7. Key Strategic Moves and Developments
  • 9.2. Oncotherm
    • 9.2.1. Company Overview
    • 9.2.2. Key Executives
    • 9.2.3. Company Snapshot
    • 9.2.4. Operating Business Segments
    • 9.2.5. Product Portfolio
    • 9.2.6. Business Performance
    • 9.2.7. Key Strategic Moves and Developments
  • 9.3. Celsius42
    • 9.3.1. Company Overview
    • 9.3.2. Key Executives
    • 9.3.3. Company Snapshot
    • 9.3.4. Operating Business Segments
    • 9.3.5. Product Portfolio
    • 9.3.6. Business Performance
    • 9.3.7. Key Strategic Moves and Developments
  • 9.4. Andromedic
    • 9.4.1. Company Overview
    • 9.4.2. Key Executives
    • 9.4.3. Company Snapshot
    • 9.4.4. Operating Business Segments
    • 9.4.5. Product Portfolio
    • 9.4.6. Business Performance
    • 9.4.7. Key Strategic Moves and Developments
  • 9.5. Pearson
    • 9.5.1. Company Overview
    • 9.5.2. Key Executives
    • 9.5.3. Company Snapshot
    • 9.5.4. Operating Business Segments
    • 9.5.5. Product Portfolio
    • 9.5.6. Business Performance
    • 9.5.7. Key Strategic Moves and Developments
  • 9.6. Nanjing Greathope
    • 9.6.1. Company Overview
    • 9.6.2. Key Executives
    • 9.6.3. Company Snapshot
    • 9.6.4. Operating Business Segments
    • 9.6.5. Product Portfolio
    • 9.6.6. Business Performance
    • 9.6.7. Key Strategic Moves and Developments
  • 9.7. Shanghai Huayuan
    • 9.7.1. Company Overview
    • 9.7.2. Key Executives
    • 9.7.3. Company Snapshot
    • 9.7.4. Operating Business Segments
    • 9.7.5. Product Portfolio
    • 9.7.6. Business Performance
    • 9.7.7. Key Strategic Moves and Developments
  • 9.8. MagForce AG
    • 9.8.1. Company Overview
    • 9.8.2. Key Executives
    • 9.8.3. Company Snapshot
    • 9.8.4. Operating Business Segments
    • 9.8.5. Product Portfolio
    • 9.8.6. Business Performance
    • 9.8.7. Key Strategic Moves and Developments
  • 9.9. Nanopores
    • 9.9.1. Company Overview
    • 9.9.2. Key Executives
    • 9.9.3. Company Snapshot
    • 9.9.4. Operating Business Segments
    • 9.9.5. Product Portfolio
    • 9.9.6. Business Performance
    • 9.9.7. Key Strategic Moves and Developments
  • 9.10. Sensius
    • 9.10.1. Company Overview
    • 9.10.2. Key Executives
    • 9.10.3. Company Snapshot
    • 9.10.4. Operating Business Segments
    • 9.10.5. Product Portfolio
    • 9.10.6. Business Performance
    • 9.10.7. Key Strategic Moves and Developments